BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8504887)

  • 1. [Transgenic animals and their means of application].
    Cartier N
    Diabete Metab; 1993; 19(1):61-7. PubMed ID: 8504887
    [No Abstract]   [Full Text] [Related]  

  • 2. [ALS models by transgenic animals].
    Aoki M; Nagai M; Kato M; Itoyama Y
    No To Shinkei; 2001 Sep; 53(9):799-807. PubMed ID: 11596474
    [No Abstract]   [Full Text] [Related]  

  • 3. Mouse models of genetic diseases.
    Leiter EH; Beamer WG; Shultz LD; Barker JE; Lane PW
    Birth Defects Orig Artic Ser; 1987; 23(3):221-57. PubMed ID: 3307936
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical symptoms of Down syndrome are manifested in transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y; Avraham KB; Schickler M; Yarom R; Knobler H
    Prog Clin Biol Res; 1990; 360():233-62. PubMed ID: 2147288
    [No Abstract]   [Full Text] [Related]  

  • 5. Knock-in and knock-out. Transgenes, Development and Disease: A Keystone Symposium sponsored by Genentech and Immunex, Tamarron, CO, USA, January 12-18, 1991.
    Roemer K; Johnson PA; Friedmann T
    New Biol; 1991 Apr; 3(4):331-5. PubMed ID: 2065017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early thymic T cell development in young transgenic mice overexpressing human Cu/Zn superoxide dismutase, a model of Down syndrome.
    Laurent J; Paly E; Marche PN; London J
    Free Radic Biol Med; 2006 Jun; 40(11):1971-80. PubMed ID: 16716898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic animals in diabetes research.
    Walther R
    Biomed Biochim Acta; 1990; 49(12):1205-9. PubMed ID: 2097993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Animal models of hereditary diseases].
    Montagutelli X; Guénet JL
    Rev Prat; 1997 Jan; 47(2):162-8. PubMed ID: 9157514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
    Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
    Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic models for chromosome 21 gene dosage effects.
    Groner Y
    Prog Clin Biol Res; 1995; 393():193-212. PubMed ID: 8545451
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomics and the meaning of life.
    Altern Lab Anim; 2004 Sep; 32(3):154. PubMed ID: 15599977
    [No Abstract]   [Full Text] [Related]  

  • 12. YAC transgenic mice in the study of the genetic basis of Down syndrome.
    Cabin DE; Hawkins A; Griffin C; Reeves RH
    Prog Clin Biol Res; 1995; 393():213-26. PubMed ID: 8545452
    [No Abstract]   [Full Text] [Related]  

  • 13. [Murine models for human diseases].
    Benavides F; Guénet JL
    Medicina (B Aires); 2001; 61(2):215-31. PubMed ID: 11374148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching molecular genetics: chapter 2-Transgenesis and gene targeting: mouse models to study gene function and expression.
    Claij N; Peters DJ
    Pediatr Nephrol; 2006 Mar; 21(3):318-23. PubMed ID: 16395602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of human genetic disease: which mouse is more like a man?
    Erickson RP
    Bioessays; 1996 Dec; 18(12):993-8. PubMed ID: 8976156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms involved in experimental insulin-dependent diabetes mellitus.
    Radu DL
    Roum Arch Microbiol Immunol; 2001; 60(3):203-26. PubMed ID: 12165974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Dalle-Donne I
    Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteome analysis in hippocampus of mice overexpressing human Cu/Zn-superoxide dismutase 1.
    Shin JH; London J; Le Pecheur M; Weitzdoerfer R; Hoeger H; Lubec G
    Neurochem Int; 2005 Jun; 46(8):641-53. PubMed ID: 15863242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A transgenic animal model: new possibilities for cardiovascular research].
    Franz WM; Frey N; Müller O; Kübler W; Katus HA
    Z Kardiol; 1995; 84 Suppl 4():17-32. PubMed ID: 8585270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.